The novel approach of this peptide represents a major breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide443372.iyublog.com/40738019/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment